Mole mapping is the process of photographing and documenting the moles on your body in a standardized way so they can be compared over time. The images form a baseline record. At each follow up the same areas are captured in the same position, lighting, and colour reference, so a mole that has grown, darkened, or changed shape is identified by comparison rather than by memory.
Mole mapping is also called total body photography or skin surveillance photography. The purpose is monitoring change, which is the single most reliable early warning sign in skin cancer detection.
What it involves at our London clinic:
Mole mapping helps almost anyone who wants to keep a closer eye on their skin. It is especially worth booking if you:
If one of these applies, imaging is still useful even if nothing looks alarming today.
A baseline recorded now is what makes a change detectable a year from now.
The most common signs of melanoma are asymmetry, an irregular border, uneven colour, a diameter larger than 6 mm, and any mole that is evolving. Dermatologists summarize these as the ABCDE rule.
If you notice any of these, book an assessment rather than waiting for your next imaging session.
Digital skin imaging is the technology that makes mole mapping reliable. Instead of an ordinary photograph, the skin is captured in multiple modes: a standard view, a polarized view that removes surface glare, a pigment view that isolates melanin, and a redness view that highlights vascular activity.
Consistent colour calibration means a colour change you see in the images is a real change in the mole, not a change in the room lighting.
Digital skin imaging is a monitoring and documentation tool. It is very good at showing whether something has changed over time. It is not a test for skin cancer. It does not diagnose, it does not detect on its own, and it cannot tell you that you are in the clear. If a spot looks concerning, the decision about what it is, and whether it needs a biopsy, belongs to your nurse practitioner, not to a camera.
Think of mole mapping as something that works alongside a skin examination, not instead of one. If you ever notice a mole that is changing quickly, bleeding, itching, or new, book an assessment rather than waiting for your next session.
Please note (disclaimer card): Mole mapping and digital skin imaging are surveillance and monitoring tools. They do not diagnose skin cancer and cannot guarantee that you are free of skin cancer or any other condition. They support, but do not replace, clinical skin examinations and any biopsies your clinician recommends.
For most people, once a year is a good interval, which gives a year-on-year record to compare.
If you are at higher risk, such as a strong family history, many atypical moles, or a previous skin cancer, your nurse practitioner may suggest doing it more often.
There is no single schedule that fits everyone, so your NP will recommend an interval based on your skin and history. In between visits, keep using the ABCDE checklist and book sooner if something changes.
A change on a photo is not a diagnosis. It is a prompt to take a closer look. If your nurse practitioner sees something worth examining, she will assess it in person and talk you through the options. That might mean simply keeping a closer eye on it, or it might mean a biopsy or removal. Pinkal Medical Aesthetics offers in-clinic mole and lesion removal, so that next step can often happen without a long wait.
A few small things help us capture the clearest images:
Mole Mapping & Digital Skin Imaging $695 + HST per session Introductory offer: the first 20 clients save $200, so $495 + HST Payment is due at the time of booking Private-pay. No referral needed. Not covered by OHIP.
Imaging gives you a baseline. Your own attention between visits is what catches change early. Watch for:
None of these confirms skin cancer. All of them are worth a look, and all of them are far easier to assess when we already have your baseline images on file.
Most people benefit from a mole check once a year, with a repeat imaging session at 6 to 12 months if you are higher risk or if a specific mole is being monitored
